| 94352-2 |
Purkinje cell cytoplasmic type Tr Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-Tr IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94352-2 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-Tr IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalopathy; Neuro; Neurology; Oncology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCA-Tr Ab; PCD; PNS; Point in time; Purkinje Cells Tr Ab; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94353-0 |
Myelopathy autoimmune Ab panel |
- |
CSF |
Pt |
- |
|
|
ACTIVE |
Myelopathy autoimmune Ab panel - Cerebral spinal fluid |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SERO |
|
94353-0 |
|
|
|
|
Order |
|
|
|
0 |
Myelopathy Ab pnl CSF |
|
|
|
|
|
Cerebral spinal fluid; Cerebrospinal Fl; Myelopathy Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 94354-8 |
Amphiphysin Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Amphiphysin IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94354-8 |
|
IF |
|
|
Both |
|
|
|
0 |
Amphiphysin IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94355-5 |
Glial nuclear type 1 Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Glial nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94355-5 |
|
IF |
|
|
Both |
|
|
|
0 |
Glial nuc type 1 IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; AGNA; AGNA-1; ANA IgG; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Glial nuc type 1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lambert-Eaton myasthenic syndrome; Neuro; Neurology; Nuc; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; Random; Serology; SmQn; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94356-3 |
Neuronal nuclear type 1 Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Neuronal nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94356-3 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu1 IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; ANA IgG; ANNA 1; ANNA-1; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type I; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94357-1 |
Neuronal nuclear type 2 Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Neuronal nuclear type 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94357-1 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu2 IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; ANA IgG; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu2; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type II; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; RI; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94358-9 |
Neuronal nuclear type 3 Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Neuronal nuclear type 3 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94358-9 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu3 IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; ANA IgG; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type III; Nuc; Oncology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94359-7 |
Glutamate decarboxylase 65 Ab.IgG+IgM |
SCnc |
CSF |
Pt |
Qn |
IA |
|
ACTIVE |
Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
SERO |
|
94359-7 |
|
IA |
|
|
Both |
|
|
|
0 |
GAD65 IgG+IgM CSF IA-sCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Insulin-Dependent Diabetes Mellitus; Level; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; SUDS |
2.68 |
2.68 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 9436-7 |
Lead |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Lead [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
9436-7 |
|
|
|
|
Both |
|
|
|
0 |
Lead Fld-mCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.7 |
1.0i |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 94360-5 |
Glial fibrillary acidic protein.alpha subunit Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94360-5 |
|
IF |
|
|
Both |
|
|
|
0 |
GFAP alpha IgG CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Traumatic Brain Injuries; TRF |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94361-3 |
Metabotropic glutamate receptor 1 Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94361-3 |
|
IF |
|
|
Both |
|
|
|
0 |
mGluR1 IgG CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; c707; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; Glu; Glutamic acid; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; mGluR1; mGluR1 Ab; mGluR1 IgG; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94362-1 |
Purkinje cell cytoplasmic type Tr Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-Tr IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94362-1 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-Tr IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalopathy; Neuro; Neurology; Oncology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCA-Tr Ab; PCD; PNS; Point in time; Purkinje Cells Tr Ab; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94363-9 |
Purkinje cell cytoplasmic type 1 Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94363-9 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-1 IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Yo Ab |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94364-7 |
Purkinje cell cytoplasmic type 2 Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
94364-7 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-2 IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94365-4 |
Bordetella pertussis DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Bordetella pertussis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94365-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
B pert DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pertussis; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94366-2 |
Streptococcus pyogenes DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Streptococcus pyogenes DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94366-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
S pyo DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; S pyogenes; Screen; SDA; Spec; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94367-0 |
Streptococcus pneumoniae DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Streptococcus pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94367-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
S pneum DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; S pneumo; S pneumoniae; S pneumoniase DNA; Screen; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94368-8 |
Streptococcus agalactiae DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Streptococcus agalactiae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94368-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Gp B Strep DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; S agalactiae; Screen; SDA; Spec; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94369-6 |
Staphylococcus aureus DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Staphylococcus aureus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94369-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
S aureus DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; S aureus; Screen; SDA; Spec; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 9437-5 |
Methylhippurate |
MRat |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Methylhippurate [Mass/time] in Urine |
|
MIN |
DefinitionDescription |
|
|
g/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
9437-5 |
|
|
|
|
Both |
|
|
|
0 |
Methylhippurate Ur-mRate |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Mass rate; Methylhippuric acid; mRate; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Xylene metabolite |
2.7 |
1.0i |
|
|
|
|
|
|
|
g/(24.h) |
|
|
|
0 |
| 94370-4 |
Serratia marcescens DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Serratia marcescens DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94370-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
S marcescens DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; S marcescens; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94371-2 |
Pseudomonas aeruginosa DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Pseudomonas aeruginosa DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94371-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
P aeruginosa DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P aeruginosa; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94372-0 |
Proteus sp DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Proteus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94372-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Proteus sp DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94373-8 |
Moraxella catarrhalis DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Moraxella catarrhalis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94373-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M catarrhalis DNA Lower Resp Ql NAA+prb |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; M catarr DNA; M catarrhalis; Microbiology; Micrococcus catarrhalis; NAA+probe; NAAT; NASBA; Neisseria catarrhalis; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 94374-6 |
Klebsiella pneumoniae DNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Klebsiella pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94374-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
K pneumon DNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K pneumon; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
